Renoprotective therapy: How good can it get?

Kidney International

Volumn 57, Issue 1, 2000, Pages 343-344

  Hebert, L A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

End stage renal disease; Genotype; Progressive renal disease; Ramipril

Indexed keywords

ANGIOTENSIN; C PEPTIDE; HOMOCYSTEINE; LIPID; RAMIPRIL;

BLOOD PRESSURE; DISEASE COURSE; DNA POLYMORPHISM; DRUG EFFICACY; EDITORIAL; FLUID INTAKE; GENE DELETION; GENE INSERTION; HOMOCYSTINURIA; KIDNEY FAILURE; LIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN INTAKE; SMOKING;

EID: 0034088070     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00852.x     Document Type: Editorial

References (9)

1. A. Perna P. Ruggenenti A. Testa B. Spoto R. Benini V. Misefari G. Remuzzi C. Zoccali ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies Kidney Int 57 2000 274 281
2. L.J. Vleming J.W. van de Pijl H.H.P.J. Lemkes R.G.J. Westerndrop J.A. Maassen M.R. Daha L.A. van Es C. van Kooten The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM Clin Nephrol 51 1999 133 140
3. S. Klahr A.S. Levey J. Beck A.W. Caggiula L. Hunsicker J.W. Kusek G. Striker Modification of Diet in Renal Disease Study Group The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease N Engl J Med 330 1994 877 884
4. Hebert LA: Target blood pressure for antihypertensive treatment of patients with proteinuric renal disease. Curr Hyperten Reports (in press)
5. L.A. Hebert J.W. Kusek T. Greene L.Y. Agodoa C.A. Jones J.A. Breyer P. Faubert H.A. Rolin S. Wang Effects of blood pressure control on progressive renal disease in blacks and whites Hypertens 30pt 1 1997 428 435
6. M.T. Pedrini A.S. Levey J. Lau T.C. Chalmers P.H. Wang The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis Ann Intern Med 24 1996 627 632
7. P.E. De Jong G. Navis D. de Zeeuw Renoprotective therapy: Titration against urinary protein excretion Lancet 354 1999 352 353 10.1016/s0140-6736(99)90122-8
8. L.A. H EBERT Glomerular diseases R.T. KUNAU T.J. NASCA American College of Physicians Nephrology and Hypertension (MKSAP) 2nd ed 1998 3 34
9. R.H. Knopp Drug treatment of lipid disorders N Engl J Med 341 1999 498 511